Long-term objective hiatal hernia recurrence after magnetic sphincter augmentation versus laparoscopic fundoplication: a multicenter cohort study of moderate and large hiatal hernias - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Long-term objective assessment of hiatal hernia recurrence following magnetic sphincter augmentation versus laparoscopic fundoplication: a multicenter cohort study in moderate-to-large hernias

  • By

  • Shahin Ayazi

  • F. P. Buckley

  • John C. Lipham

  • Philip Woodworth

  • Mark S. Shachner

  • Carlos J. Anciano

  • Vineeth Sadda

  • Kate Freeman

  • Rachel Heidrick

  • Reginald C. W. Bell

  • October 13, 2026

Share

Clinical Scorecard: Long-term Objective Assessment of Hiatal Hernia Recurrence Following Magnetic Sphincter Augmentation Versus Laparoscopic Fundoplication

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Long-term objective assessment of hiatal hernia recurrence following magnetic sphincter augmentation versus laparoscopic fundoplication
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationAdults aged 21 years or older who underwent primary laparoscopic repair with MSA or fundoplication for an intraoperatively verified hiatal hernia of at least 3 cm and had objective postoperative assessment at 3 years.
Care SettingCare setting described in the source article.

Key Highlights

  • The study compared objective hiatal hernia recurrence after MSA and laparoscopic fundoplication for moderate (3–5 cm) or large (>5 cm or paraesophageal) hernias.
  • Objective recurrence was defined as more than 2 cm of the stomach, fundoplication wrap, or MSA device above the diaphragm on contrast esophagram or upper endoscopy.
  • Eligibility required objective postoperative assessment at 3 years; contrast esophagram was used for assessment at approximately 3 or 5 years, with endoscopy used when esophagram was unavailable.
  • Secondary outcomes included GERD-related quality of life, proton pump inhibitor use, patient satisfaction, and revision surgery for recurrent hernia.
  • Procedure choice was not protocolized and was guided by anatomy, esophageal physiology, operative era, and surgeon preference.

Guideline-Based Recommendations

Diagnosis

  • For this study, recurrence was assessed objectively using contrast esophagram or upper endoscopy.
  • Baseline hernia size was classified from intraoperative findings as moderate (3–5 cm) or large (>5 cm or paraesophageal).

Management

  • Both study procedures included laparoscopic hernia reduction and crural repair.
  • Fundoplication consisted of complete (360°) or partial (180° or 270°) wraps; MSA was implanted using previously described sizing and placement methods.

Monitoring & Follow-up

  • Eligibility required objective postoperative assessment at 3 years. Contrast esophagram assessed hiatal repair at approximately 3 or 5 years; when esophagram was unavailable, the operating surgeon assessed recurrence by upper endoscopy.
  • Secondary outcomes included GERD-HRQL, proton pump inhibitor use, patient satisfaction, and revision surgery for recurrent hernia.

Risks

  • The article identifies recurrent hiatal hernia as a major mechanism underlying procedural failure and a predominant indication for revisional antireflux surgery.
  • The article notes that objective anatomical recurrence can occur even when patient-reported outcomes remain favorable.

Patient & Prescribing Data

The cohort screened adults undergoing primary laparoscopic hiatal hernia repair with MSA or fundoplication for hernias of at least 3 cm; exclusions included revisional procedures, hernias under 3 cm, and absent objective follow-up at 3 years.

MSA and fundoplication were compared in an observational cohort. Procedure selection was based on patient anatomy and esophageal physiology, operative era, and surgeon preference rather than a study protocol.

Clinical Best Practices

  • The study defined objective recurrence as more than 2 cm of stomach, wrap, or MSA device above the diaphragm on esophagram or endoscopy.
  • Interpret comparative findings in light of the observational design and non-protocolized procedure selection.
  • The study assessed objective anatomical recurrence separately from symptom-based outcomes.

Related Resources & Content

Original Source(s)

Related Content